A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
Recruiting · NCT06905873 · Registry updated 2025-11-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo | Skin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligo | Recruiting | Phase 1 | 2025-11-20 | NCT06905873 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Forte Biosciences, Inc. | 4 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cornerstone Dermatology | Coorparoo | Australia | 3 |
| Momentum Pukehoke | Auckland | New Zealand | 1 |
| Novatrials | Kotara | Australia | 3 |
| Optimal Clinical Trials Central | Auckland | New Zealand | 1 |
| Optimal Clinical Trials North | Auckland | New Zealand | 1 |
| Skin & Cancer Foundation Australia - The Skin Hospital | Darlinghurst | Australia | 1 |